tecartushcp.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
#updated 01/28/2021 User-agent:* Sitemap: https://www.tecartushcp.com/sitemap.xml # End | ||
Meta Tags
| Title | CAR T for R/R MCL and R/R B-cell ALL | TECARTUS® HCP |
| Description | Learn about TECARTUS® (brexucabtagene autoleucel), a CAR T‐cell therapy indicated for adults with R/R mantle cell lymphoma and adults with R/R B-cell precursor acute lymphoblastic leukemia. See Important Safety |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 40.70.27.35 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
tecartushcp.com Valuation
|
US$6,220,192
Last updated: 2023-05-17 04:20:17
tecartushcp.com has Semrush global rank of 1,701,604. tecartushcp.com has an estimated worth of US$ 6,220,192, based on its estimated Ads revenue. tecartushcp.com receives approximately 717,715 unique visitors each day. Its web server is located in United States, with IP address 40.70.27.35. According to SiteAdvisor, tecartushcp.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$6,220,192 |
| Daily Ads Revenue | US$5,742 |
| Monthly Ads Revenue | US$172,252 |
| Yearly Ads Revenue | US$2,067,018 |
| Daily Unique Visitors | 47,848 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| tecartushcp.com. | A | 14400 | IP: 40.70.27.35 |
| tecartushcp.com. | NS | 14400 | NS Record: dns2.cscdns.net. |
| tecartushcp.com. | NS | 14400 | NS Record: dns1.cscdns.net. |
| tecartushcp.com. | MX | 14400 | MX Record: 10 custmx.cscdns.net. |
| tecartushcp.com. | TXT | 14400 | TXT Record: mwsauthsprod-wr.azurewebsites.net |
HtmlToTextCheckTime:2023-05-17 04:20:17
| TECARTUS ® (brexucabtagene autoleucel) is a CD19-directed genetically modified autologous T cell immunotherapy indicated Read more + TECARTUS ® (brexucabtagene autoleucel) is a CD19-directed genetically modified autologous T cell immunotherapy indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (MCL). This indication is approved under accelerated approval based on overall response rate and durability Read more + TECARTUS ® (brexucabtagene autoleucel) is a CD19-directed genetically modified autologous T cell immunotherapy indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (MCL). This indication is approved under accelerated approval based on overall response rate and durability of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial. TECARTUS is a CD19-directed genetically modified autologous T cell |
HTTP Headers
HTTP/1.1 301 Moved Permanently Content-Length: 0 Content-Type: text/html; charset=UTF-8 Location: https://tecartushcp.com/ Date: Sat, 05 Mar 2022 08:55:09 GMT HTTP/2 301 content-length: 0 location: https://www.tecartushcp.com/ server: Microsoft-IIS/10.0 x-powered-by: ASP.NET set-cookie: ARRAffinity=a5cc361951b831c47c239c35a7ca880100928a265555b6cb831a5084ab1230ed;Path=/;HttpOnly;Secure;Domain=tecartushcp.com set-cookie: ARRAffinitySameSite=a5cc361951b831c47c239c35a7ca880100928a265555b6cb831a5084ab1230ed;Path=/;HttpOnly;SameSite=None;Secure;Domain=tecartushcp.com date: Sat, 05 Mar 2022 08:55:10 GMT HTTP/2 200 date: Sat, 05 Mar 2022 08:55:11 GMT content-type: text/html; charset=utf-8 cache-control: no-cache, no-store pragma: no-cache expires: -1 vary: Accept-Encoding set-cookie: ARRAffinity=222dca18de1accb16870a959ce6229d7a942c7de07883732698d7dbc4fe79ff4;Path=/;HttpOnly;Secure;Domain=wwwea.tecartushcp.com set-cookie: ARRAffinitySameSite=222dca18de1accb16870a959ce6229d7a942c7de07883732698d7dbc4fe79ff4;Path=/;HttpOnly;SameSite=None;Secure;Domain=wwwea.tecartushcp.com request-context: appId=cid-v1:55ccabae-b43f-4c3b-b830-58b5ec6c8319 cf-cache-status: DYNAMIC expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct" server: cloudflare cf-ray: 6e71a1956c1c1660-DME |
tecartushcp.com Whois Information
Domain Name: TECARTUSHCP.COM Registry Domain ID: 2571658053_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.corporatedomains.com Registrar URL: http://cscdbs.com Updated Date: 2021-11-07T06:04:14Z Creation Date: 2020-11-11T08:05:57Z Registry Expiry Date: 2022-11-11T08:05:57Z Registrar: CSC Corporate Domains, Inc. Registrar IANA ID: 299 Registrar Abuse Contact Email: domainabuse@cscglobal.com Registrar Abuse Contact Phone: 8887802723 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: DNS1.CSCDNS.NET Name Server: DNS2.CSCDNS.NET DNSSEC: unsigned >>> Last update of whois database: 2022-03-05T09:56:53Z <<< |